| 1 |
35378500 | Insulin like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor. | 2022 May |
1 |
| 2 |
32426479 | RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease. | 2020 May |
2 |
| 3 |
29492662 | Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities. | 2018 Aug |
1 |
| 4 |
24599591 | Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. | 2014 Mar 25 |
1 |
| 5 |
22709943 | Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease. | 2012 Aug |
1 |
| 6 |
22753408 | Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism. | 2012 Aug 10 |
1 |
| 7 |
23209759 | Elevated homocysteine by levodopa is detrimental to neurogenesis in parkinsonian model. | 2012 |
3 |
| 8 |
22131969 | Ras-ERK Signaling in Behavior: Old Questions and New Perspectives. | 2011 |
1 |
| 9 |
20808799 | Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. | 2010 Aug 23 |
4 |
| 10 |
18410512 | Striatal histone modifications in models of levodopa-induced dyskinesia. | 2008 Jul |
2 |
| 11 |
15686961 | L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. | 2005 Mar |
3 |